2014
DOI: 10.1159/000362693
|View full text |Cite
|
Sign up to set email alerts
|

Should We Really Compare Indwelling Pleural Catheters to Any Pleurodesis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 38 publications
0
5
0
Order By: Relevance
“…Talc is currently the best sclerosing agent shown to be effective, safe, and cheap and providing long-lasting results [3] . Pleurodesis is achieved mostly by talc insufflation into the pleural cavity performed under thoracoscopy [3] .…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Talc is currently the best sclerosing agent shown to be effective, safe, and cheap and providing long-lasting results [3] . Pleurodesis is achieved mostly by talc insufflation into the pleural cavity performed under thoracoscopy [3] .…”
Section: Resultsmentioning
confidence: 99%
“…Talc is currently the best sclerosing agent shown to be effective, safe, and cheap and providing long-lasting results [3] . Pleurodesis is achieved mostly by talc insufflation into the pleural cavity performed under thoracoscopy [3] . Thoracoscopic pleurodesis is reserved for patients with a good health status and a relatively long life expectancy, in whom a histological diagnosis and anatomic and molecular staging of the disease, lead to changes in the treatment strategy [12] .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…They found that there was similar effectiveness of quality adjusted life years (QALYs), however talc pleurodesis was less costly (talc, 0.281 QALYs and $8170.80; Pleurx, 0.276 QALYs and $9011.60) [ 21 ]. Froudarakis compared the cost of repeated thoracentesis and pleurodesis and found that repeat thoracentesis was the cheapest intervention at three-month survival where bedside pleurodesis became the cheapest at 12-month analysis (thoracentesis $4946; pleurodesis $13057) [ 22 ]. However, Froudarakis felt that indwelling pleural catheters were difficult to compare to other treatments because patient selection, techniques, and complications are different with these devices [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…Froudarakis compared the cost of repeated thoracentesis and pleurodesis and found that repeat thoracentesis was the cheapest intervention at three-month survival where bedside pleurodesis became the cheapest at 12-month analysis (thoracentesis $4946; pleurodesis $13057) [ 22 ]. However, Froudarakis felt that indwelling pleural catheters were difficult to compare to other treatments because patient selection, techniques, and complications are different with these devices [ 22 ]. More research comparing quality adjusted life years, cost and complications is recommended for future studies.…”
Section: Discussionmentioning
confidence: 99%